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Streptococcus intermedius is a human pathogen with a propensity for abscess formation. We report a high-quality draft genome
sequence of S. intermedius strain BA1, an isolate from a human epidural abscess. This sequence provides insight into the biology
of S. intermedius and will aid investigations of pathogenicity.
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Streptococcus intermedius is a member of the anginosus or Strep-tococcus milleri group (SMG), which also includes S. constella-
tus and S. anginosus (1). This organism is part of the normal mi-
crobiota of human mucosal surfaces, including the upper
respiratory and lower genital tracts, and can cause liver and brain
abscesses, bacteremia, osteoarticular infections, and endocarditis
(2–5). SMG bacteria are also newly recognized as likely pathogens
in cystic fibrosis pulmonary infections (6). The strain BA1 was
isolated from an intracranial abscess in a child who presented with
complicated mastoiditis and osteomyelitis of the skull. The iden-
tification of the organism was confirmed by PCR and sequencing
of the 16S rRNA genes and the gene encoding intermedilysin
(ILY) (7).
The whole genome sequence of S. intermedius BA1 was deter-
mined using a hybrid approach including Roche/454 GS-FLX se-
quencing (593,795 reads; 378-bp average read length) and Pacific
Biosciences (PacBio) R.S. sequencing (319,206 reads; 1,122-bp av-
erage read length). The sequencing errors of single-molecule reads
were corrected by mapping 454 reads onto longer PacBio R.S.
reads using an algorithm previously described (8). The resulting
24,599 corrected PacBio R.S. reads larger than 2,000 bp were as-
sembled using Newbler (version 2.7) and yielded 49 contigs with a
total size of 1,966,076 bp (N50, 209,077 bp) and 30-fold genome
coverage. Fourteen long (10-kbp) contigs contained
1,896,811 bp in total (96.5% of the genome sequence). Annota-
tion was performed using the IGS prokaryotic annotation engine
(9). The genome sequence has a GC content of 37.8%, 63 tRNA
genes, 6 rRNA genes, and 2,028 predicted coding sequences (with
an average gene length of 848 nucleotides [nt]) comprising 87% of
the genome.
The complement of putative virulence factors identified in the
annotated draft genome sequence of S. intermedius BA1 has con-
siderable similarity to those described for S. pneumoniae. S. inter-
medius BA1 contains a coding sequence for ILY, a human-specific
pore-forming toxin closely related to vaginolysin from Gardner-
ella vaginalis and inerolysin fromLactobacillus iners (10, 11). ILY is
important in S. intermedius pathogenesis (12–14), and its produc-
tion is regulated by sensation of nutrient availability via the catab-
olite control protein A (15), which is also encoded in the S. inter-
medius BA1 draft genome sequence. Capsular polysaccharide
synthesis (cps) is involved in immune evasion by pathogenic
streptococci (16), and the S. intermedius BA1 genome encodes
proteins predicted to be involved in cps pathways. Natural
competence for transformation is a driving force in streptococ-
cal evolution (17, 18), and competence pathway components
similar to those of S. pneumoniae were identified in the BA1
genome, as was a predicted competence-stimulating peptide
precursor. Genes for sortases and their predicted substrates
containing consensus LPXTG motifs, two-component signal-
ing systems, adhesins, sialidases, quorum-sensing components,
and a eukaryotic-like serine-threonine protein kinase/phospha-
tase pair (PrkC/PrpC) were also identified. No predicted sidero-
phore genes were noted in the BA1 genome.
Nucleotide sequence accession numbers. The sequence from
this Whole Genome Shotgun project has been deposited in DDBJ/
EMBL/GenBank under accession number ANFT00000000 (Bio-
Project PRJNA178554, SubID SUB138006). The version de-
scribed in this paper is the first version, ANFT01000000.
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